Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Rheumatology and Therapy|February 22, 2024
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic ArthritisJeffrey R Curtis, Iain B McInnes, Proton Rahman, et al.
The Journal of Rheumatology. Supplement|June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement SetYing Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
Therapeutic Advances in Musculoskeletal Disease|November 13, 2024
Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studiesLars Erik Kristensen, William Tillett, Peter Nash, et al.
The Journal of Rheumatology|August 1, 2024
The Development and Validation of a Novel Training Infographic for the Physician Global Visual Analog Scale in Psoriatic ArthritisShannon Gunawardana, Philip S Helliwell, Marc R Kok, et al.
The Journal of Rheumatology|May 3, 2015
Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014William Tillett, Lihi Eder, Niti Goel, et al.
Annals of the Rheumatic Diseases|December 4, 2020
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2Philip J Mease, Apinya Lertratanakul, Jaclyn K Anderson, et al.
Seminars in Arthritis and Rheumatism|August 16, 2021
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PFYing-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, et al.
Seminars in Arthritis and Rheumatism|September 14, 2020
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic reviewYing-Ying Leung, Richard Holland, Ashish J Mathew, et al.
Advances in Therapy|August 10, 2022
The Effect of Guselkumab on General Health State in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 TrialJeffrey R Curtis, Iain B McInnes, Proton Rahman, et al.
The Journal of Rheumatology|June 3, 2014
Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual MeetingMaarten de Wit, Willemina Campbell, Oliver FitzGerald, et al.
Pageof 13